AG Reaches $90 million Agreement over Unlawful Drug Promotion

The Tennessee Attorneys General office, along with 37 other Attorneys General, reached a $90 million agreement with GlaxoSmithKline LLC to resolve allegations that GlaxoSmithKline unlawfully promoted its diabetes drug Avandia by engaging in unfair and deceptive practices by misrepresenting Avandia’s cardiovascular risks and safety profile. Tennessee will receive $3 million as part of this multistate consumer protection investigation. Download the press release.

AttachmentSize
GSK_Avandia_press_release_11152012.pdf122.62 KB